SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-20-001233
Filing Date
2020-10-05
Accepted
2020-10-05 08:30:25
Documents
3
Period of Report
2020-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k12566001_10052020.htm 8-K 17455
2 ex101to8k12566001_10052020.htm EX-10.1 105683
3 ex991to8k12566001_10052020.htm EX-99.1 9278
  Complete submission text file 0001193805-20-001233.txt   133731
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 201222370
SIC: 2834 Pharmaceutical Preparations